• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. PROTECTA XT CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. PROTECTA XT CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number D354TRM
Device Problem Device Sensing Problem (2917)
Patient Problems Pneumonia (2011); Heart Failure (2206)
Event Date 04/06/2018
Event Type  Injury  
Manufacturer Narrative
This information is based entirely on journal literature.Since no device id was provided, it is unknown if this event has been previously reported.Request for additional information will be made and upon receipt a supplemental report will be submitted accordingly.Referenced article: a case of a cardiac resynchronization therapy-defibrillator exhibiting a lower and alternately variable basic rate.International heart journal.2018; 59(3):626-629.Doi: 10.1536/ihj.17-235.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was reviewed which contained information regarding a patient with a cardiac resynchronization therapy-defibrillator (crt-d).The article reports three years after crt-d implantation, the patient was admitted to the hospital with pneumonia and exacerbation of heart failure.The patient developed atrial tachycardia (at) with a cycle length of 550-600 ms, which led to inadequate biventricular pacing in the programmed in ddi mode.In addition, the at was being under-sensed by the atrial lead.It was noted that the lengths of some cycles were observed to be longer than the programmed setting.Atrial pacing fell within the non-competitive atrial pacing (ncap) interval after his basic rate was reprogrammed to 100 beats/minute, thereby delaying atrial pacing to occur just after the ncap period.The device remains in use.No further patient complications have been reported as a result of this event.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received through follow up which included the model number of the device.No further information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTECTA XT CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer (Section G)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
lisa robertson
8200 coral sea st ne
mounds view, MN 55112
7635262723
MDR Report Key7775061
MDR Text Key116851409
Report Number2182208-2018-01473
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberD354TRM
Device Catalogue NumberD354TRM
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/16/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-